Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation

Leukemia and Lymphoma

Volumn 35, Issue 3-4, 1999, Pages 339-345

  Mcbride, N C ^a   Ward, M C ^a   Mills, M J ^b   Eden, A G ^b   Hughes, A ^b   Cavenagh, J D ^a   Lamont, A ^b   Newland, A C ^a   Kelsey, S M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b St Bartholomew's Hospital ^*

Author keywords

EPIC lymphoma relapse salvage chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; PREDNISOLONE;

ADULT; AGED; ALOPECIA; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW SUPPRESSION; BRAIN DISEASE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PLEURA EFFUSION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0032706816     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145738     Document Type: Article

References (19)

1. Linch, D.C., Winfield, D., Goldstone A.H., Moir, D., Hancock, B., McMillan, A.K., Chopra, R., Milligan, D., Vaughan Hudson, G. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet; 341: 1051-54
2. Chopra, R., McMillan, A. K., Linch, D.C., Yuklea, S., Taghipour, G., Pearce, R., Patterson, K G., Goldstone, A.H. (1993) The place of High-Dose BEAM Therapy and Autologous Bone Marrow Transplantation in Poor risk Hodgkin's disease. A single centre eight-year study of 155 patients. Blood 81, no 5 1137-1145
3. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffer, B., Biron, P., Mandelli, F. and Chauvin, F. (1995) Autologous bone marrow transplantation as compared to salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
4. Chopra, R., Linch, D.C., McMillan, A. K., Blair, S., Patterson, K. G., Moir, D., Richards, J M., Cervi, P., Kinsey, S. and Goldstone A.H. (1992) Mini-Beam followed by BEAM and ABMT for very poor risk Hodgkin's disease. British Journal of Haematology, 81, 197-202.
5. Prince, H.M., Imrie, K., Chrump, M., Stewart, K., Girouard, C., Colwill, R., Brabdwein, J., Tsang, R.W., Gerald Scott, J., Sutton, D.M.C., Pantalony, D., Carstairs, K., Sutcliffe, S.B. and Keating, A. (1996) The role of intensive therapy an autologous blood and marrow transplantation for chemotherapy sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups. British Journal of Haematology: 92: 880-889.
6. Sweetenham, JW., Taghipour, G., Milligan, D., Blystad, A.K., Caballero, D., Passas, A., Goldstone, A.H. (1997) High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Bone Marrow Transplantation 20: 745-52.
7. Hickish, T., Roldan, A., Cunningham, D., Mansi, J., Ashley, S., Nicolson, V., Gore, M.E., Catovsky, D. and Smith, I.E. (1993) EPIC: an effective low toxicity regimen for relapsing lymphoma. British. Journal of Cancer, 81, 1137-145.
8. Richardson, D.S., Tighe, M., Cull, M., Johnson, S.A. and Phillips, M.J. (1994) Salvage chemotherapy for Relapsed and Resistant Lymphoma with a Carboplatin Containing Schedule - EPIC. Haematological Oncology, 12, 125-128.
9. Millar A.B., Hoogstraten B., Staquet M., Winkler A. (1981) Reporting results of cancer treatment. Cancer, 47, 207-214.
10. Philip, T., Armitage, J.O., Spitzer, G., Chauvin, F., Jagannath, S., Cahn, J.Y., Colombat, P., Goldstone, A.H., Gorin, N.C., Flesh, H., Laporte, J.P., Maraninchi, D., Pico, J., Bosly, A., Anderson, C., Schots, R., Biron, P., Cabanillas, F. and Dicke, K. (1987) High dose chemotherapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New England Journal of Medicine, 316, 1493-1498.
11. Philip, T., Biron, P., Maraninchi, D., Gastaut, J.A., Herve, P., Flesh, Y., Goldstone, A.H. and Souhami, R.L. (1984) Role of massive chemotherapy and autologous bone marrow transplantation in Non-Hodgkin's malignant lymphoma. Lancet, 1:391
12. Mills, W., Chopra, R., McMillan, A., Pearce, R., Linch, D.C., Goldstone, A.M. (1995) BEAM chemotherapy with autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. Journal of Clinical Oncology, 13: 588-595.
13. Appelbaum, F.R., Sullivan, K.M., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Hill, R., Mortimer, J., Neiman, P.E., Sanders, J.E. (1987) Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. Journal of Clinical Oncology. 5(9):1340-7.
14. Velasquez, W.S. Mclaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Romaguera, J., Rubenstein, E. and Cabanillas F. (1994) ESHAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study. Journal of Clinical Oncology, 12, No 6 1169-1179.
15. Girouard, C., Dufresne, J., Imrie, K., Stewart, A.K., Brandwein, J., Prince, H.M., Pantolony, D., Keating, A., Crump, M. (1997) Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation. Annals of Oncology. 8(7):675-80.
16. Velasquez, W.S., Cabanillas, F., Salvador, P., McLaughin, P., Fridrik, M., Tucker, S., Jagannath, S., Hagemeister, F.B., Redman, J.R., Swan, F., Barlogie, B. (1988) Effective salvage therapy for lymphoma with ciplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood, 71; 117-122.
17. Wilson, W.H., Bryant, G., Bates, S., Fojo, A., Wittes, R.E., Steinberg, S.M., Kohler, D.R., Jaffe, E.S., Herdt, J., Cheson, B.D. and Chabner, B.A. (1993) EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. Journal of Clinical Oncology 11, 1573-82.
18. Child, J.A., Johnson, S.A.N., Smith, G.M., Johnson, P.W.M., Prentice, A.G. (1996) Fludarabine enhanced dexamethasone, cytosine and cisplatinum for recurrent / refractory aggressive Non-Hodgkin's Lymphoma. Blood 88. (suppl 1) abstr 2267.
19. Grigg, A., Chapman, R.,. Szer, J. (1998) Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine. Bone Marrow Transplantation. 21(6):619-21